- Tumor markers in ovarian cancer2018 | Faculty of Medicine in Hradec Králové
- Lysophosphatidic Acid in Patients With Ovarian Cancer2010 | Faculty of Medicine in Hradec Králové
- The use of niraparib in the treatment of ovarian cancer2023 | First Faculty of Medicine
- Prognostic signifikance of Pgp, MRP1, and MRP3 in ovarian cancer patients2015 | Faculty of Medicine in Hradec Králové
- Chemoresistance/chemosensitivity in vitro in ovarian cancer patients2011 | Faculty of Medicine in Hradec Králové
- Cancer stem cells - possibility of targeted therapy of ovarian cancer?2015 | Faculty of Medicine in Pilsen
- Dedifferentiated carcinoma of the ovary. A case report2018 | First Faculty of Medicine
- Drug resistence proteins and PFS in ovarian cancer patients2013 | Faculty of Medicine in Hradec Králové
- Benefits of multidisciplinary approach in the management of ovarian cancer2019 | First Faculty of Medicine
- The importance of angiogenesis for the growth of ovarian cancer and the impact of bevacizumab2014 | Faculty of Medicine in Hradec Králové
- Surgical resection of ovarian cancer: past, present and future2010 | Publication without faculty affiliation
- Cardiotoxicity of antitumor drugs in ovarian cancer patients2015 | Faculty of Medicine in Hradec Králové
- Genetic testing in ovarian cancer2022 | First Faculty of Medicine
- Proteins of resistance and Drug Resistance in Ovarian Carcinoma2012 | Faculty of Medicine in Hradec Králové
- Cancer stem cells in ovarian cancer2012 | Faculty of Medicine in Pilsen
- Karcinom ovaria2018 | First Faculty of Medicine
- Diagnosis of ovarian cancer2006 | First Faculty of Medicine
- Cardiotoxicity of anticancer treatment in patients with ovarian cancer2017 | Faculty of Medicine in Hradec Králové
- Diagnostic tools and prognostic factors in the most malignant gynecological cancer - epithelial ovarian cancer2013 | First Faculty of Medicine
- Vascular endothelial growth factor in ovarian cancer patients2012 | Faculty of Medicine in Hradec Králové
- Screening karcinomu ovaria2018 | First Faculty of Medicine
- Niraparib expands the availability of maintenance therapy in patients with advanced high-grade ovarian cancer2022 | Faculty of Medicine in Pilsen
- Antiangiogenic therapy for ovarian cancer2013 | First Faculty of Medicine
- Controversies in the treatment of ovarian cancer2013 | Third Faculty of Medicine
- Primary drug resistance/sensitivity in vitro and clininical outcome in ovarian cancer patients2011 | Faculty of Medicine in Hradec Králové
- Proteomics and biomarkers for detection of ovarian cancer2009 | Faculty of Medicine in Hradec Králové
- Systémová léčba karcinomu ovaria2018 | First Faculty of Medicine
- Proteomics and biomarkers for detection of ovarian cancer2009 | First Faculty of Medicine
- Primary pure large-cell neuroendocrine carcinoma of the ovary2008 | First Faculty of Medicine
- Lymfadenektomie a operační léčby karcinomu ováriaPublication without faculty affiliation